130 related articles for article (PubMed ID: 6230755)
1. Platelet activation caused by cardiac catheter blood collection, and its prevention.
Mant MJ; Kappagoda CT; Taylor RF; Quinlan JE
Thromb Res; 1984 Jan; 33(2):177-87. PubMed ID: 6230755
[TBL] [Abstract][Full Text] [Related]
2. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
3. Platelet function in blood sampled through heart catheters.
Thaulow E
Acta Med Scand; 1984; 216(2):187-92. PubMed ID: 6238506
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation.
Bugiardini R; Chierchia S; Crea F; Gallino A; Wild S; Roskovec A; Lenzi S; Maseri A
Am Heart J; 1984 Aug; 108(2):255-60. PubMed ID: 6205577
[TBL] [Abstract][Full Text] [Related]
5. Serial determinations of PF4 and beta TG: comparisons between multiple venipunctures vs a catheter infusion system.
Strauss W; Cella G; Myers C; Sasahara AA
Thromb Haemost; 1988 Jun; 59(3):491-4. PubMed ID: 2973152
[TBL] [Abstract][Full Text] [Related]
6. Serial studies of platelet factor 4 and beta thromboglobulin during exercise in patients with coronary artery disease.
Strauss WE; Cella G; Parisi AF; Sasahara AA
Am Heart J; 1985 Aug; 110(2):293-9. PubMed ID: 2411121
[TBL] [Abstract][Full Text] [Related]
7. Beta-thromboglobulin (beta tg) and platelet factor 4 (PF4) in patients with myeloproliferative diseases.
Fabris F; Luzzatto G; Randi ML; Cella G
Thromb Haemost; 1994 Sep; 72(3):484-6. PubMed ID: 7710537
[No Abstract] [Full Text] [Related]
8. Lack of effect of exercise on platelet activation and platelet reactivity.
Mant MJ; Kappagoda CT; Quinlan J
J Appl Physiol Respir Environ Exerc Physiol; 1984 Nov; 57(5):1333-7. PubMed ID: 6240477
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
Ferri GM; Afeltra A; Caccavo D; Amoroso A
Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
[No Abstract] [Full Text] [Related]
10. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
11. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
12. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
[No Abstract] [Full Text] [Related]
13. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
[TBL] [Abstract][Full Text] [Related]
14. Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
Cella G; Colby SI; Taylor AD; McCracken L; Parisi AF; Sasahara AA
Thromb Res; 1983 Mar; 29(5):499-509. PubMed ID: 6222505
[TBL] [Abstract][Full Text] [Related]
15. [Platelets and migraine. Correlation between biochemical markers of platelet aggregation and serotonin].
Leira R; Castillo J; Martínez F; Castro A; Lema M; Noya M
Neurologia; 1991 Jan; 6(1):10-2. PubMed ID: 1830748
[TBL] [Abstract][Full Text] [Related]
16. Heparin-releasable platelet factor 4 in patients with coronary artery disease.
Sadayasu T; Nakashima Y; Yashiro A; Kawashima T; Kuroiwa A
Clin Cardiol; 1991 Sep; 14(9):725-9. PubMed ID: 1835913
[TBL] [Abstract][Full Text] [Related]
17. beta-Thromboglobulin, platelet production time and pletelet function in vascular disease.
Cella G; Zahavi J; de Haas HA; Kakkar VV
Br J Haematol; 1979 Sep; 43(1):127-36. PubMed ID: 92336
[TBL] [Abstract][Full Text] [Related]
18. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
[TBL] [Abstract][Full Text] [Related]
20. Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves.
Bellon JL; Castellanos C; Acevedo L; Amiral J
Semin Thromb Hemost; 1993; 19 Suppl 1():178-82. PubMed ID: 8362264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
